PFEPFIZER INC

NYSE pfizer.com


$ 27.70 $ 0.52 (1.91 %)    

Thursday, 02-May-2024 15:59:58 EDT
QQQ $ 429.07 $ 3.83 (0.9 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 0.61 (0.12 %)
TLT $ 88.87 $ 0.31 (0.35 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 27.7
$ 27.09
$ 0.00 x 0
$ 0.00 x 0
$ 27.08 - $ 27.93
$ 25.20 - $ 38.81
97,521,564
na
158.14B
$ 0.57
$ 74.63
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-08-2023 10-01-2023 10-Q
3 08-09-2023 07-02-2023 10-Q
4 05-10-2023 04-02-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-09-2022 10-02-2022 10-Q
7 08-10-2022 07-03-2022 10-Q
8 05-11-2022 04-03-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-12-2021 10-03-2021 10-Q
11 08-12-2021 07-04-2021 10-Q
12 05-13-2021 04-04-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-05-2020 09-27-2020 10-Q
15 08-06-2020 06-28-2020 10-Q
16 05-07-2020 03-29-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 11-07-2019 09-29-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 02-28-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-09-2018 07-01-2018 10-Q
24 05-10-2018 04-01-2018 10-Q
25 02-22-2018 12-31-2017 10-K
26 11-09-2017 10-01-2017 10-Q
27 08-10-2017 07-02-2017 10-Q
28 05-11-2017 04-02-2017 10-Q
29 02-23-2017 12-31-2016 10-K
30 11-10-2016 10-02-2016 10-Q
31 08-11-2016 07-03-2016 10-Q
32 05-12-2016 04-03-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-05-2015 09-27-2015 10-Q
35 08-06-2015 06-28-2015 10-Q
36 05-07-2015 03-29-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 11-06-2014 09-28-2014 10-Q
39 08-07-2014 06-29-2014 10-Q
40 05-08-2014 03-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pfizer-prospects-garner-mixed-sentiment-from-analysts-finally-the-pivot-investors-have-been-waiting-for

Pfizer analysts from Goldman see a positive outlook on Padcev, Prevnar, and Vindaqel, but Nurtec and Oxbryta execution needs work.

 morgan-stanley-maintains-equal-weight-on-pfizer-raises-price-target-to-29

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $28 to...

 bmo-capital-reiterates-outperform-on-pfizer-raises-price-target-to-36

BMO Capital analyst Evan David Seigerman reiterates Pfizer (NYSE:PFE) with a Outperform and raises the price target from $33...

 pfizer-unusual-options-activity
Pfizer Unusual Options Activity
05/02/2024 13:46:48

 carvana-enovix-pfizer-nio-tesla-why-these-5-stocks-are-on-investors-radars-today

Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase a...

 us-stocks-mixed-ahead-of-fed-meeting-chipmakers-tumble-after-amd-earnings-bitcoin-sinks-whats-driving-markets-wednesday

Traders are treading cautiously in Wednesday’s session, seeking more clarity on the Federal Reserve’s stance with inflation rep...

 pfizer-exec-says-co-is-progressing-on-retail-contracting-for-rsv-vaccine-rsv-vaccine-performance-was-in-line-with-expectations-in-qtr-patent-term-extension-if-granted-could-extend-us-exclusivity-for-heart-disease-drug-vyndamax-to-dec-2028

-Conf. Call

 pfizer-embraces-direct-to-consumer-model-for-covid-antiviral-says-comirnaty-revenues-continue-to-perform-consistently-with-expectations

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlov...

 gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Sp...

 pfizer-q1-2024-adj-eps-082-beats-054-estimate-sales-1490b-beat-1420b-estimate

Pfizer (NYSE:PFE) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.54 by 51.85 pe...

 ft-earlier-reported-pfizer-to-sell-covid-and-migraine-drugs-directly-to-consumers

https://www.ft.com/content/4e7a2bc7-0de7-4948-bfd3-bda210e56c12

 wall-street-set-to-open-lower-after-amd-earnings-disappoint-as-traders-look-to-feds-powell-for-relief-why-this-analyst-sees-incoming-summer-rally

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION